Dr. Keith A. Bellovich, DO

Dr. Bellovich practices at St. Clair Nephrology, Idaho Nephrology Associates in Utica, Michigan.

Dr. Bellovich's NPI, 1467454009, was assigned on August 12, 2005. Dr. Bellovich graduated from Michigan State University College Of Osteopathic Medicine in 1989. Dr. Bellovich holds Michigan license KB010619.

Dr. Bellovich's primary practice is St. Clair Nephrology, Idaho Nephrology Associates, at 45640 Schoenherr Rd, Utica, MI 48315 in Macomb County. The practice phone is (586) 218-5800.

Dr. Bellovich's primary practice is St. Clair Nephrology, Idaho Nephrology Associates in Utica, Michigan. Dr. Bellovich is also affiliated with Henry Ford Hospital. The medical group on file is St. Clair Nephrology. Dmand AI also links Dr. Bellovich to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bellovich practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bellovich's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bellovich is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Bellovich's licenses on file in 2 states: Michigan and Colorado.

Dmand AI lists chronic kidney disease and kidney disease among the conditions Dr. Bellovich treats.

CMS data shows 180 Medicare services from Dr. Bellovich across 2 procedure codes in 2024, for 46 Medicare patients. Medicare paid $5,937 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Dr. Bellovich in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bellovich's median patient age at 70, with 46% women.

In 2024, Dr. Bellovich wrote 416 Medicare Part D claims for 65 patients. 85% of them were for generic drugs. CMS names the drug for 263 of them, across 12 drugs with 11 or more claims each, at $44,926 in total drug cost. In 2023, CMS named 313 claims across 16 drugs.

Dr. Bellovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Bellovich, published from 2010 to 2023. 2011 was the busiest year, with 4. The most frequent topics are Renal Insufficiency, Chronic, Glomerular Filtration Rate and Calcium. Dr. Bellovich has published most often in Am J Kidney Dis. Dr. Bellovich's most frequent co-authors are Zeenat Yousuf Bhat, MD, Crystal A. Gadegbeku, MD and Susan Steigerwalt, MD.

Dmand AI links Dr. Bellovich to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Polycystic Kidney, Autosomal Dominant, Polycystic Kidney Diseases and Nephrotic Syndrome.

CMS Open Payments shows 32 general payments to Dr. Bellovich from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $3,908.

Dmand AI lists 4 awards for Dr. Bellovich, most recently CMS Stage 1 EHR in 2011.

Dr. Bellovich graduated from Michigan State University College Of Osteopathic Medicine in 1989. Dr. Bellovich is a member of AOA and ASN.

Dr. Bellovich is in network with 11 carriers, including Aetna, Elevance and Health Alliance Plan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.